p53: traffic cop at the crossroads of DNA repair and recombination

Cited by (106)

Items 101–106 of 106

1. LET-dependent survival of irradiated normal human fibroblasts and their descendents
   Hamada, Nobuyuki, Funayama, Tomoo, Wada, Seiichi, Sakashita, Tetsuya, Kakizaki, Takehiko, Ni, Meinan, Kobayashi, Yasuhiko · 2006 · Radiation Research
2. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
   Calvisi, Diego F., Simile, Maria M., Ladu, Sara, Frau, Maddalena, Evert, Matthias, Tomasi, Maria L., Demartis, Maria I., Daino, Lucia, Seddaiu, Maria A., Brozzetti, Stefania et al. · 2011 · Hepatology
3. Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
   Lan, Yulong, Lou, Jiacheng, Hu, Jiliang, Yu, Zhikuan, Lyu, Wen, Zhang, Bo · 2020 · Cancer Biology and Medicine
4. Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model
   Tonsing-Carter, Eva, Bailey, Barbara J., Saadatzadeh, M. Reza, Ding, Jixin, Wang, Haiyan, Sinn, Anthony L., Peterman, Kacie M., Spragins, Tiaishia K., Silver, Jayne M., Sprouse, Alyssa A. et al. · 2015 · Molecular Cancer Therapeutics
5. Reassessing the role of p53 in cancer and ageing from an evolutionary perspective
   Aranda-Anzaldo, Armando, Dent, Myrna A.R. · 2007 · Mechanisms of Ageing and Development
6. Etoposide-induced dna damage is increased in p53 mutants: identification of atr and other genes that influence effects of p53 mutations on top2-induced cytotoxicity
   Menendez, Daniel, Anand, Jay R., Murphy, Carri C., Bell, Whitney J., Fu, Jiaqi, Slepushkina, Nadia, Buehler, Eugen, Martin, Scott E., Lal-Nag, Madhu, Nitiss, John L. et al. · 2022 · Oncotarget